Headlines

Two major studies strengthen case for prostate cancer drug before chemotherapy

The pioneering prostate cancer drug abiraterone can significantly extend the lives of men with advanced prostate cancer if administered prior to administering chemotherapy, according to phase III clinical trial data.

Single therapy offers improved survival in younger patients with limited brain metastases

Single therapy offers improved survival in younger patients with limited brain metastases

Data clearly demonstrated stereotactic radiosurgery (SRS) alone offered benefits for younger patients with limited metastases.

Use of adjuvant systemic therapy increasing for gastrointestinal stromal tumors (GIST)

Use of adjuvant systemic therapy increasing for gastrointestinal stromal tumors (GIST)

Localized gastrointestinal stromal tumors (GISTs) are rarely seen, but are the most common sarcomas in the gastrointestinal tract.

People who drink 3-5 cups of coffee per day less likely to develop clogged arteries

People who drink 3-5 cups of coffee per day less likely to develop clogged arteries

People who drink a moderate amount of coffee each day are less likely to develop clogged arteries that could cause heart attacks.

Statin hyporesponders may have blocked arteries

Statin hyporesponders may have blocked arteries

Low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications.

Link between nasal allergies increased risk of nasopharyngeal cancer

Link between nasal allergies increased risk of nasopharyngeal cancer

Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma (NPC), according to a study.

Location of colorectal cancer impacts survival chances

Location of colorectal cancer impacts survival chances

Poorer outcome seen in study when tumor began on the organ's right side

Study may support active surveillance for favorable intermediate-risk prostate cancer

New research suggests that active surveillance may be an initial approach for men with favorable intermediate-risk prostate cancer.

Most commonly used treatment for prostate cancer is radiotherapy

A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.

Conference Coverage

Novel tool predicts postoperative liver cancer recurrence after transplant

The risk of disease recurrence in liver cancer patients who have undergone a liver transplant can now be more accurately calculated, thanks to new tool.

Surgery may not be necessary for some patients with rectal cancer

Patients with rectal cancer that experienced a complete response had similar 4-year survival rates regardless of whether they had immediate surgery or pursued a watch-and-wait approach.

Long-term outcomes improved by combining bevacizumab with newer chemotherapy regimen for advanced colorectal cancer

A phase III study of patients with metastatic colorectal cancer has indicated that FOLFOXIRI chemotherapy, in combination with bevacizumab, is superior to the standard FOLFIRI chemotherapy with bevacizumab.

Young adults with acute lymphoblastic leukemia (ALL) benefit from therapies developed for children

There is increasing evidence that adolescent and young adult patients with acute lymphoblastic leukemia (ALL) tend to fare better when treated with high-intensity pediatric protocols than standard adult regimens.

PRM-151 therapy well tolerated by patients with advanced myelofibrosis

The compound PRM-151 (PRM) has shown success in reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs